Annual Meeting
The Westin, Perth
28-29 March 2026
8:30 - 10:30
Session 1: Opening Plenary
Chair: Dr Jessica Yang; Moderator: Dr Divya Mehta
8:30 - 8:40
Dr Jessica Yang
8:40 - 9:15
Prof Harriet Thoeny
- To be familiar with the most frequent solid renal lesions
- To know the typical imaging findings of the most frequent malignant and benign renal lesion
- To understand the impact on management
9:15 - 9:45
Prof Maxime Ronot
- Recognize the key clinical and imaging features of acute mesenteric ischemia
- Identify CT findings distinguishing arterial, venous, and non-occlusive etiologies
- Discuss the imaging features of ischemia and necrosis
- Appreciate the role of imaging in guiding urgent therapeutic decision-making and improving outcomes
9:45 - 10:15
Prof Stephanie Nougaret
- Identify imaging features relevant to patient selection for cytoreductive surgery with or without HIPEC, including patterns of peritoneal disease, bowel involvement, and contraindications to complete cytoreduction
- Understand the impact of of pre- and post-treatment imaging
- Provide structured and surgically actionable reports addressing key questions for gynecologic oncologists during MDT discussions
10:15 - 10:30
10:30 - 11:00
Morning Tea
11:00 - 12:30
Session 2A: Liver
Chair: Dr Chris McKee; Moderator: Dr Duncan Ramsay
11:00 - 11:30
Prof Maxime Ronot
- Review the spectrum of vascular liver disorders, including portal vein thrombosis, Budd–Chiari syndrome, and porto-sinusoidal vascular disorder.
- Describe characteristic imaging patterns across CT, MRI, and ultrasound
- Integrate imaging findings into multidisciplinary management strategies
- Understand the characteristics of focal lesions developed in patients with VLD
11:30 - 11:55
Dr James Seow
- Overview the history, importance and definitions of hepatic steatosis
- Evaluate the evidence behind the qualitative & quantitative methods of assessment on US, CT & MRI
- Review some practical considerations when reporting studies with hepatic steatosis
11:55 - 12:20
A/Prof Tom Sutherland
- When to use MRI
- Contrast selection
- Common lesions in a normal liver
- Common lesions in CLD
- What to say when you have absolutely no idea - and someone has seen you open the study, so it’s officially yours
12:20 - 12:30
11:00 - 12:30
Session 2B: Prostate
Chair: Dr Mitchell Raeside; Moderator: Dr Justin Hegarty
11:00 - 11:30
Prof Harriet Thoeny
- To be familiar with the PI-RADS version 2.1 scoring system
- To understand the impact of prostate MRI for patient management
- To know the PRECISE version 2 score as well as PI-RR scoring system
11:30 - 11:50
Dr Richard Pemberton (Urologist)
- What aspects on MRI reports are helpful/ unhelpful for a Urologist
- How MRI can assist in shared patient - clinician decision making in choosing between prostate cancer treatment options
- Limitations of MRI prostate
11:50 - 12:20
Prof Harriet Thoeny
- To become familiar with pitfalls in MR imaging of the prostate
- To understand the etiological role of technical, physiological and perception factors
- To develop strategies in order to avoid them
12:20- 12:30
12:30 - 1:30
Lunch
1:30 - 3:00
Session 3A: Rectal
Chair: Dr Katerina Mastrocostas; Moderator: Dr Jennifer Shoobridge
1:30 - 2:00
Prof Stephanie Nougaret
- Apply high-resolution pelvic MRI for accurate primary rectal cancer staging, including assessment of T stage, mesorectal fascia involvement, extramural vascular invasion, tumor deposit, and nodal disease
- Recognize imaging features that stratify patients into low-, intermediate-, and high-risk groups and directly influence neoadjuvant treatment strategies
- Avoid common staging pitfalls, particularly in low rectal tumors, mucinous tumors, and post-biopsy or inflammatory changes
2:00 - 2:25
A/Prof Kirsten Gormly
- How to approach a restaging MRI
- The new ESGAR restaging guidelines in Australia
- The concept of near Complete Clinical Response
2:25 - 2:50
Prof Stephanie Nougaret
- Understand the indications and surgical principles of pelvic exenteration and the critical role of imaging in patient selection
- Perform a systematic MRI evaluation of pelvic resectability, including pelvic sidewall, neurovascular structures, bone involvement, and multivisceral disease
- Communicate imaging findings effectively to surgeons, focusing on decision-changing features and potential limits to surgical clearance
2:50 - 3:00
1:30 - 3:00
Session 3B: Short Topics
Chair: Dr Ravinder Dhillon; Moderator: Dr Rose Thomas
1:30 - 1:45
Dr Jyothirmayi Velaga
- Recognize key CT patterns in acute female pelvic emergencies using case based examples
- Understand the role of CT as a problem solving tool
- Identify high risk imaging features that should prompt urgent clinical escalation
1:45 - 2:00
Dr Rory McPherson
- Identify time critical pathologies needing urgent intervention
a. Vascular eg active bleeding, pseudoaneurysm
b. Non-vascular – biliary sepsis, obstructed urosepsis etc
- When to call surgery or IR?
- Pre-call checklist
a. Coagulation profile
b. Medications
c. Access issues (aneursyms, celiac trunk stenosis, can it be drained?)
2:00 - 2:15
Dr Narelle Vujcich
Learning objectives (include but not limited to):
- Appraise anatomy to assess internal hernias etc
- Evaluate clinical and ct features to differentiate causes of enteritis other than crohns
- Recognise early sx of sb ischaemia
2:15 - 2:30
Dr Geertje Noë
- Recognise subtle signs of “hidden” pancreatic cancer, especially as changes in surrounding tissues rather than a distinct lesion
- Use this knowledge to improve awareness of early signs and improve detection of pancreatic cancer in general radiology practice
2:30 - 2:45
Dr Madusha Chandratilleke
- How to confidently diagnose appendicitis (or not) – it’s not just about the size
- US tips on detection of malrotation
- Trouble shooting large abdominal masses – how to decide on origin and invasion
2:45 - 3:00
3:00 - 3:30
Afternoon Tea
3:30 - 5:00
Session 4A: Abdomen
Chair: Dr Numan Kutaiba; Moderator: Dr Manil Chouhan
3:30 - 3:45
Dr Anand Trivedi (Surgeon)
- Utility and limitations of ultrasound in groin hernias
- How collaboration between radiologists, surgeons and GPs can save time and resources
- Synoptic reporting for ventral hernias and abdominal wall reconstruction
3:45 - 4.00
Dr Arj Somasundaram
- Diagnosis and categorisation of groin hernias
- Common mimics of groin hernias
- How and why to perform pre-hernia surgery abdominal wall Botox injection
4:00 - 4:15
Dr Kate McLean
- Review diagnosis and imaging features GI tract neuroendocrine tumours
- Illustrate management considerations using clinical cases
4:15 - 4:30
Dr Janelle Morris
- To understand which MRI sequences are useful in characterising perianal fistulas
- To develop a simple method of reporting perianal fistula MRI
4:30 - 4:45
Dr Kevin Ho
- Recognise the imaging features of abdominal vascular compression, in particular arterial compression
- Understand vascular compression on imaging is often asymptomatic and requires clinical correlation
4:45 - 5:00
3:30 - 5:00
Session 4B: Gynae
Chair: Dr Penny Symes; Moderator: Dr Sharon Winter
3:30 - 4:00
Prof Stephanie Nougaret
- Understand the key updates of the new FIGO staging system and how imaging integrates with histologic and molecular risk stratification
- Accurately assess myometrial invasion, cervical stromal involvement, and extra-uterine spread on MRI in accordance with updated staging criteria
- Adapt radiology reports to support contemporary risk-adapted management, including surgical planning and adjuvant treatment decisions
4:00 - 4:20
Dr Stuart Salfinger (Gynaecologic Oncologist)
- Understand how gynaecological oncological surgeons use imaging to determine operability, surgical intent, and operative approach across major gynaecological malignancies
- Identify imaging features that most strongly influence surgical decision-making
- Appreciate which radiological findings matter most to surgeons at different disease sites (ovarian, endometrial, and cervical), and how these findings should be prioritised in reports
4:20 - 4:35
Dr Jade Acton (Gynaecologist)
- Understand how detailed MRI assessment of fibroid size, number, FIGO classification, and anatomical relationships directly influences gynaecologic surgical planning and intraoperative risk.
- Identify the key MRI features that surgeons rely on when choosing between hysteroscopic, laparoscopic, open myomectomy, or hysterectomy approaches
- Recognise MRI findings that alter surgical strategy, including features suspicious for malignancy and co-existing pelvic pathology such as adenomyosis or endometriosis
- Apply a surgeon-focused reporting approach by prioritising MRI findings that impact feasibility, complexity, and safety of fibroid surgery, including myometrial thickness, serosal distance, vascularity, and adjacent organ involvement
4:35 - 4:50
A/Prof Glen Lo
- Crash course/refresh on the 2022 MUSA revised definitions because few sonographers seem to have heard of them
- Consider the same findings are visible on MRI as on TVUS
4:50 - 5.00
5:00 - 5:45
Welcome Drinks
Industry Exhibition
7:00 - 11:00
Meeting Dinner
Fraser’s Function Centre, King's Park
8:30 - 10:30
Session 5: Plenary and MRP
Chair: Dr Nick Kenning; Moderator: Dr Murray Di Loreto
8:30 - 9:00
Prof Maxime Ronot
- Apply current imaging criteria for the non-invasive diagnosis of HCC using LI-RADS.
- Recognize hallmarks of hepatocarcinogenesis and understand their imaging counterparts
- Understand emerging concepts of prognostic imaging biomarkers in HCC
- Appreciate how imaging can support treatment selection
9:00 - 9:30
Prof Harriet Thoeny
- In this session Prof Thoeny will show various cases with focal renal lesions including take home messages
9:30 - 9:50
Dr Jash Agraval
- How to write a clinically relevant report, with discussions on how to measure nodes, look for involvement in extra nodal sites
- Node necrosis - what does this mean
- How to recognise and report treatment changes, and how to predict transformation, with insights into molecular imaging and its specific utility
9:50 - 9:55
9:55 - 10:04
Dr Kirsten Biddle
10:04 - 10:13
Dr Claire Ephraums
10:13 - 10:21
Dr Ishita Patel
10:21 - 10:30
Dr Minh-Son To
10:30 - 11:00
Morning Tea
11:00 - 1:00
Session 6: Liver and MDT
Chair: Dr James Seow; Moderator: Dr Matt Van Wyk
11:00 - 11:20
Dr Dilini Gunawardena (Pathologist)
- Review of general histological features and differential diagnosis
- Update on subtyping based on molecular findings and morphological and immunophenotypic correlation
11:20 - 11:40
Dr Mark Goodwin
- Review the use hepatocyte specific contrast agent, how they work and how to interpret the findings vs extracellular contrast agents
- Learn about the imaging features of the different subtypes of hepatic adenomas, specifically, review the similarities between the beta-catenin exon 3 subtype and FNH
- Learn about the management of the different subtypes of hepatic adenomas, including suspected beta-catenin exon 3 subtype
11:50 - 1:00
Dr James Seow (Chair), Dr Adam Doyle (Hepatologist), Dr Dilini Gunawardena (Pathologist), Dr Himanshu Pendse (Interventional Radiologist), Dr Joelin Teh (Radiologist), Mr Joshua Salim (Surgeon), with Prof Maxime Ronot (International Guest)
1:00 - 1:15
ARGANZ Annual General Meeting
Lunch
1:00 - 2:00
2:00 - 4:00
Session 7: Cases, Short Topics and Quiz
Chair: Dr Chris Welman; Moderator: Dr Mayooran Kandasamy
2:00 - 2:05
Dr Jessica Yang, Prof Richard Mendelson
2:05 - 2:45
Prof Maxime Ronot
- Approach complex abdominal imaging cases using a structured and practical diagnostic framework
- Discuss pitfalls and challenging differential diagnoses in daily practice
- Discuss the role of radiologists in multidisciplinary, case-driven discussion
2:45 - 2:55
Dr Katharina Lampichler
2:55 - 3:05
Dr Sian Chin
- Have an understanding of the commonly used CT and MRI contrast media agents
- Understand the potential adverse effects of contrast media agents and how risk can be mitigated
3:05- 3:15
Dr Shriv Srigandan
3:15- 3:25
A/Prof Tom Sutherland
- The part two oral exam has changed since we all did it and it continues to evolve. A brief outline is provided to enable radiologists to prepare their registrars and exam candidates
3:25 - 3:30
3:30 - 3:50
Dr Arj Somasundaram
- Challenge your assumptions
- Pursue greatness
- Become one with abdominal radiology
3:50 - 4:00
Dr Jessica Yang
12.5 RANZCR CPD hours may be claimed for attending the ARGANZ 2026 Annual Scientific Meeting to be held 28-29 March 2026.
In addition, the following Program Level Requirements may be claimed: Professionalism and Addressing Health Inequities.